MVŽ1 - Anti-cancer ovarian and uterine examination program - The program consists of the main cancer markers that increase in ovarian or uterine cancer. PS: These cancer signs cannot be used for prophylaxis. Cancer markers are used to correct diagnosis and monitor the course of cancer treatment.
MVŽ2 - Antitumor extended ovarian and uterine examination program - The program consists of cancer markers, which usually increase with ovarian and uterine cancer. PS: These cancer signs cannot be used for prophylaxis. Cancer markers are used to correct diagnosis and monitor the course of cancer treatment.
MVŽ1 74 € |
MVŽ2 95 € |
|||
CA 125 (ovarian cancer marker) | + | + | ||
CA 19-9 (pancreatic cancer marker) | + | + | ||
CA 15-3 (breast cancer marker) | ||||
CEA (carcinoembryonic antigen) | + | + | ||
HE-4 | + | + | ||
ROMA index | + | + | ||
α-Fetoprotein (AFP) | + | |||
Chorionic gonadotropin (HCG) | + | |||
ThinPrep liquid cytological assay | ||||
HPV 16, 18 with high risk genotyping selection | ||||
(PSA) | ||||
Free PSA |
The cost of test sample collection - 4€